Cheng‐Xiong Xu

2.7k total citations
77 papers, 2.1k citations indexed

About

Cheng‐Xiong Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Cheng‐Xiong Xu has authored 77 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 26 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Cheng‐Xiong Xu's work include MicroRNA in disease regulation (16 papers), Cancer-related molecular mechanisms research (11 papers) and PI3K/AKT/mTOR signaling in cancer (9 papers). Cheng‐Xiong Xu is often cited by papers focused on MicroRNA in disease regulation (16 papers), Cancer-related molecular mechanisms research (11 papers) and PI3K/AKT/mTOR signaling in cancer (9 papers). Cheng‐Xiong Xu collaborates with scholars based in China, South Korea and United States. Cheng‐Xiong Xu's co-authors include Hua Jin, Myung‐Haing Cho, Meng Xu, Chong‐Su Cho, Dhananjay Jere, Qing Li, Wenzhi Bi, Rohidas Arote, J.H. Hendry and Zhigang Song and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Cheng‐Xiong Xu

76 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng‐Xiong Xu China 29 1.3k 695 307 300 194 77 2.1k
Yang Dong China 27 1.1k 0.8× 426 0.6× 218 0.7× 210 0.7× 75 0.4× 89 2.0k
Chunli Luo China 25 1.3k 1.0× 639 0.9× 272 0.9× 284 0.9× 64 0.3× 109 2.0k
Kee-Ho Lee South Korea 20 1.2k 0.9× 296 0.4× 597 1.9× 119 0.4× 122 0.6× 35 2.2k
Huimin Sun China 25 1.2k 0.9× 660 0.9× 251 0.8× 348 1.2× 81 0.4× 121 2.0k
Zhao Chen China 23 1.9k 1.4× 731 1.1× 609 2.0× 144 0.5× 73 0.4× 72 2.5k
Jiancheng Zhou China 25 1.3k 0.9× 546 0.8× 880 2.9× 463 1.5× 91 0.5× 48 2.1k
Jin Tao China 24 910 0.7× 442 0.6× 502 1.6× 352 1.2× 147 0.8× 52 1.9k
Yi Fan China 24 1.3k 0.9× 650 0.9× 243 0.8× 143 0.5× 97 0.5× 76 1.9k
Yingqi Zhang China 28 1.3k 1.0× 482 0.7× 471 1.5× 241 0.8× 112 0.6× 127 2.8k

Countries citing papers authored by Cheng‐Xiong Xu

Since Specialization
Citations

This map shows the geographic impact of Cheng‐Xiong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Xiong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Xiong Xu more than expected).

Fields of papers citing papers by Cheng‐Xiong Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Xiong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Xiong Xu. The network helps show where Cheng‐Xiong Xu may publish in the future.

Co-authorship network of co-authors of Cheng‐Xiong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Xiong Xu. A scholar is included among the top collaborators of Cheng‐Xiong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Xiong Xu. Cheng‐Xiong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Hao, Bin Hu, Jing Chen, et al.. (2024). The miR-23a/27a/24 − 2 cluster drives immune evasion and resistance to PD-1/PD-L1 blockade in non-small cell lung cancer. Molecular Cancer. 23(1). 285–285. 11 indexed citations
2.
Li, Qing, Hao Luo, Fuqiang Dai, et al.. (2023). SAMD9 Promotes Postoperative Recurrence of Esophageal Squamous Cell Carcinoma by Stimulating MYH9‐Mediated GSK3β/β‐Catenin Signaling. Advanced Science. 10(11). e2203573–e2203573. 22 indexed citations
3.
Li, Qing, Mengsheng Deng, Rentao Wang, et al.. (2022). PD-L1 upregulation promotes drug-induced pulmonary fibrosis by inhibiting vimentin degradation. Pharmacological Research. 187. 106636–106636. 28 indexed citations
4.
Zhou, Zhi-Wei, Chiara Ambrogio, Asim K. Bera, et al.. (2020). KRASQ61H Preferentially Signals through MAPK in a RAF Dimer-Dependent Manner in Non–Small Cell Lung Cancer. Cancer Research. 80(17). 3719–3731. 33 indexed citations
5.
Zhao, Xiaolong, Mengxia Li, Xiaoyan Dai, et al.. (2020). Downregulation of exosomal miR‑1273a increases cisplatin resistance of non‑small cell lung cancer by upregulating the expression of syndecan binding protein. Oncology Reports. 44(5). 2165–2173. 18 indexed citations
6.
Zhang, Liang, Mengxia Li, Bo Deng, et al.. (2019). <p>HLA-DQB1 expression on tumor cells is a novel favorable prognostic factor for relapse in early-stage lung adenocarcinoma</p>. Cancer Management and Research. Volume 11. 2605–2616. 16 indexed citations
7.
Weng, Changmei, Qing Li, Kuijun Chen, et al.. (2019). Bleomycin induces epithelial-to-mesenchymal transition via bFGF/PI3K/ESRP1 signaling in pulmonary fibrosis. Bioscience Reports. 40(1). 30 indexed citations
8.
Li, Mengxia, et al.. (2018). APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma. Cell Death and Disease. 9(11). 1111–1111. 30 indexed citations
9.
Challa, Sridevi, Xiaowen Ding, Cheng‐Xiong Xu, et al.. (2016). IKBKE Is a Substrate of EGFR and a Therapeutic Target in Non–Small Cell Lung Cancer with Activating Mutations of EGFR. Cancer Research. 76(15). 4418–4429. 30 indexed citations
10.
Xu, Meng, et al.. (2014). Decreased Expression of miR216a Contributes to Non–Small-Cell Lung Cancer Progression. Clinical Cancer Research. 20(17). 4705–4716. 51 indexed citations
11.
Xu, Meng, Zhigang Song, Cheng‐Xiong Xu, et al.. (2013). IL-17A Stimulates the Progression of Giant Cell Tumors of Bone. Clinical Cancer Research. 19(17). 4697–4705. 19 indexed citations
12.
Xu, Meng, Cheng‐Xiong Xu, Wenzhi Bi, et al.. (2013). Effects of endostar combined multidrug chemotherapy in osteosarcoma. Bone. 57(1). 111–115. 36 indexed citations
13.
Wang, Zheng, Yi‐Long Wu, Julie L. Yang, et al.. (2011). EGFR tyrosine kinase inhibitor in advanced non-small cell lung cancer with wild-type EGFR.. Journal of Clinical Oncology. 29(15_suppl). e18072–e18072. 1 indexed citations
14.
Xu, Cheng‐Xiong, Yikun Li, Ping Yue, et al.. (2011). The Combination of RAD001 and NVP-BEZ235 Exerts Synergistic Anticancer Activity against Non-Small Cell Lung Cancer In Vitro and In Vivo. PLoS ONE. 6(6). e20899–e20899. 63 indexed citations
15.
Xu, Cheng‐Xiong, Hua Jin, Hwang-Tae Lim, et al.. (2010). Low Dietary Inorganic Phosphate Stimulates Lung Tumorigenesis Through Altering Protein Translation and Cell Cycle in K-rasLA1Mice. Nutrition and Cancer. 62(4). 525–532. 13 indexed citations
16.
Jin, Yongcheng, Hong‐Gu Lee, Cheng‐Xiong Xu, et al.. (2009). Proteomic analysis of endogenous conjugated linoleic acid biosynthesis in lactating rats and mouse mammary gland epithelia cells (HC11). Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1804(4). 745–751. 11 indexed citations
17.
Jin, Hua, Cheng‐Xiong Xu, Sung Jin Park, et al.. (2008). High Dietary Inorganic Phosphate Increases Lung Tumorigenesis and Alters Akt Signaling. American Journal of Respiratory and Critical Care Medicine. 179(1). 59–68. 114 indexed citations
18.
Xu, Cheng‐Xiong, Dhananjay Jere, Hua Jin, et al.. (2008). Poly(ester amine)-mediated, Aerosol-delivered Akt1 Small Interfering RNA Suppresses Lung Tumorigenesis. American Journal of Respiratory and Critical Care Medicine. 178(1). 60–73. 82 indexed citations
19.
Xu, Cheng‐Xiong, Hong‐Gu Lee, Jihui Wang, et al.. (2006). Production of Lean Beef Containing a High Content oftrans-10,cis-12Conjugated Linoleic Acid by Feeding a High-Temperature-Micro-Time-Treated Diet with Extruded Soybean. Bioscience Biotechnology and Biochemistry. 70(11). 2589–2597. 8 indexed citations
20.
Xu, Cheng‐Xiong, et al.. (1989). [Cytocidal action of homoharringtonine on L1210 cells in vitro].. PubMed. 10(6). 546–60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yang Dong Breakdown of academic impact, for papers by Chunli Luo Breakdown of academic impact, for papers by Kee-Ho Lee Breakdown of academic impact, for papers by Huimin Sun Breakdown of academic impact, for papers by Zhao Chen Breakdown of academic impact, for papers by Jiancheng Zhou Breakdown of academic impact, for papers by Jin Tao Breakdown of academic impact, for papers by Yi Fan Breakdown of academic impact, for papers by Yingqi Zhang
Rankless by CCL
2026